Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Morus alba flavonoid extract refers to the complex mixture of flavonoids isolated from different parts of the Morus alba (white mulberry) plant, including leaves, fruits, root bark, and cortex. The extract is rich in diverse flavonoids (such as morusin, moracin D, sanggenol L, kuwanon G, quercetin, kaempferol, rutin, isoquercitrin, etc.), known for their broad pharmacological activities. Its mechanisms of action include inhibition of α-glucosidase and protein tyrosine phosphatase 1B (PTP1B), activation of AMP-activated protein kinase (AMPK), inhibition of PI3K/Akt/mTOR and Wnt3a/FOXM1/β-catenin signaling pathways, and modulation of cellular oxidative stress and inflammatory signaling. Morus alba flavonoid extract exhibits antidiabetic, antioxidant, anti-inflammatory, anti-cancer, antihyperlipidemic, and neuroprotective effects. The developer is not a single entity; the product is used as a traditional medicine and dietary supplement, and manufactured or formulated by various companies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morus alba flavonoid extract.